Interaction of antioxidant gene variants and susceptibility to type 2 diabetes mellitus

References

• Kharroubi AT, Darwish HM. Diabetes mellitus: the epidemic of the century. World J Diabetes. 2015;6:850–867.
   PubMed Web of Science ®Google Scholar
• Moore DJ, Gregory JM, Kumah-Crystal YA, et al. Mitigating micro- and macro- vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag. 2009;5:1015–1031.
   PubMedGoogle Scholar
• Forouzanfar MH, Afshin A, Alexander LT, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1659–1724.
   PubMed Web of Science ®Google Scholar
• Haldar SR, Chakrabarty A, Chowdhury S, et al. Oxidative stress-related genes in type 2 diabetes: association analysis and their clinical impact. Biochem Genet. 2015;53:93–119.
   PubMed Web of Science ®Google Scholar
• Vats P, Sagar N, Singh TP, et al. Association of superoxide dismutases (SOD1 and SOD2) and glutathione peroxidase 1 (GPx1) gene polymorphisms with type 2 diabetes mellitus. Free Radic Res. 2015;49:17–24.
   PubMed Web of Science ®Google Scholar
• Shi YY, He L. SHEsis is a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;(2005:97–98.
   Google Scholar
• Gautam S, Agrawal CG, Banerjee M. CD36 gene variants in early prediction of type 2 diabetes mellitus. Genet Test Mol Biomarkers. 2015;19:144–149.
   PubMed Web of Science ®Google Scholar
• Saxena M, Srivastava N, Banerjee M. Cytokine gene variants as predictor of Type 2 diabetes mellitus. Curr Diabetes Rev. 2017;13:1–13.
   Google Scholar
• Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118:1723–1735.
   PubMed Web of Science ®Google Scholar
• Negi G, Kumar A, Joshi RP, et al. Oxidative stress and diabetic neuropathy: current status of antioxidants. Inst Integr Omics Appl Biotechnol J. 2011;2:71–78.
   Google Scholar
• Vats P, Kushwah AS, Banerjee M. Association of antioxidant gene variants with type 2 diabetes mellitus in different ethnic groups. Eur J Biomed Pharm Sci. 2017;4:290–298.
   Google Scholar
• Abbas M, Kushwaha VS, Srivastava K, et al. Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer. Br J Biomed Sci. 2018;75:169–174.
   PubMed Web of Science ®Google Scholar
• Vats P, Chandra H, Banerjee M. Glutathione S-transferase and Catalase gene polymorphisms with Type 2 diabetes mellitus. Dis Mol Med. 2013;1:46–53.
   Google Scholar
• Verma S, Sagar N, Vats P, et al. Antioxidant enzyme levels as markers for type 2 diabetes mellitus. ‎Int J Bioassays. 2013;2:685–690.
   Google Scholar
• Bid H, Konwar R, Agrawal C, et al. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian J Med Sci. 2008;62:259–266.
   PubMedGoogle Scholar
• Saxena M, Agrawal CG, Bid HK, et al. An interleukin-10 gene promoter polymorphism (−592A/C) associated with type 2 diabetes: a North Indian study. Biochem Genet. 2012;50:549–559.
   PubMed Web of Science ®Google Scholar
• Saxena M, Vats P, Agrawal K, et al. Expression of macrophage scavenger receptor CD36 in humans – its implication in type 2 diabetes mellitus. Ann Biol Res. 2012;3:3015–3021.
   Google Scholar
• Saxena M, Srivastava N, Banerjee M. Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus. Mol Biol Rep. 2013;40:6271–6279.
   PubMed Web of Science ®Google Scholar
• Saxena M, Agrawal CG, Srivastava N, et al. Interleukin-6 (IL-6)-597 A/G (rs1800797) &-174 G/C (rs1800795) gene polymorphisms in type 2 diabetes. Indian J Med Res. 2014;140:77–85.
   PubMed Web of Science ®Google Scholar
• Saxena M, Srivastava N, Banerjee M. IL-1β, IL-1Ra and IL-18 gene variants in type 2 diabetes. J Chem Pharm Res. 2015;7:560–567.
   Google Scholar
• Gautam S, Agrawal CG, Bid HK, et al. Preliminary studies on CD36 gene in type 2 diabetic patients from north India. Indian J Med Res. 2011;134:107–112.
   PubMed Web of Science ®Google Scholar
• Banerjee M, Gautam S, Saxena M, et al. Association of CD36 gene variants rs1761667 (G> A) and rs1527483 (C> T) with Type 2 diabetes in North Indian population. Int J Diabetes Mellit. 2010;2:179–183.
   Google Scholar
• Gautam S, Agrawal CG, Banerjee M. Study of CI962235 (Ins1361A), rs3212018 (16 bp del) and rs1049673 (GC) CD36 gene polymorphisms in T2DM patients of North India. Indian J Med Sci. 2013;13:439–445.
   Google Scholar
• Gautam S, Banerjee M. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Mol Genet Metab. 2011;102:389–398.
   PubMed Web of Science ®Google Scholar
• Gautam S, Pirabu L, Agrawal CG, et al. CD36 gene variants and their association with type 2 diabetes in an Indian population. Diabetes Technol Ther. 2013;15:680–687.
   PubMed Web of Science ®Google Scholar
• Bjørklund G, Chirumbolo S. Role of oxidative stress and antioxidants in daily nutrition and human health. Nutrition. 2017;33:311–321.
   PubMed Web of Science ®Google Scholar
• Janssens ACJW, Moonesinghe R, Yang Q, et al. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med. 2007;(2007:528–535.
   Web of Science ®Google Scholar
• Bid HK, Konwar R, Saxena M, et al. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J Postgrad Med. 2010;56:176–181.
   PubMed Web of Science ®Google Scholar
• Chistyakov DA, Savostanov KV, Zotova EV, et al. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet. 2001;2:4–10.
   PubMed Web of Science ®Google Scholar
• Nomiyama T, Tanaka Y, Nagasaka LPK, et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet. 2003;48:138–141.
   PubMed Web of Science ®Google Scholar
• Ascencio-Montiel IJ, Parra EJ, Valladares-Salgado A, et al. SOD2 gene Val16Ala polymorphism is associated with macroalbuminuria in Mexican Type 2 Diabetes patients: a comparative study and meta-analysis. BMC Med Genet. 2013;14:110–118.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Choi MG. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients. Metabolism. 2006;55:1681–1688.
   PubMed Web of Science ®Google Scholar